SUBSCRIBE
SUBSCRIBE
News   Business

China BioPharma Ltd. Appoints Dr. Yimin Yu, Current Chairman Of HYTE Research To Advisory Board

April 20, 2006 | 
1 min read
ISELIN, N.J.--(BUSINESS WIRE)--April 20, 2006--Techedge Inc. (OTCBB:TEDG - News) announced that China BioPharma, Ltd. has appointed Dr. Yimin Yu, the current Chairman of HYTE Research, LLC to the company's Board of Advisors.
People
MORE ON THIS TOPIC
Business growth or increase in professional income, business operations, investment profits or interest on savings, increase in interest rates, businessman holding gold coins forming a growing arrow symbol.
Drug pricing
Pfizer Leads Industry-Wide Surge in Drug Prices for 2026 Despite Political Pressure
January 2, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Abstract creative financial graph with finger clicks on a digital tablet on background, forex and investment concept.
Legal
Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme
December 23, 2025
 · 
2 min read
 · 
Nick Paul Taylor
Hands offering money with a circular chart at the center, symbolizing shareholder equity, crowdfunding, business partnerships, and investments
IPO
Radiopharma-Focused Aktis Squeezes in IPO To End Biotech Drought
December 22, 2025
 · 
1 min read
 · 
Annalee Armstrong
Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.
China
AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor
December 22, 2025
 · 
1 min read
 · 
Annalee Armstrong